| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.17 | 2e-05 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0006 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0008 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0008 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0009 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |